Millennium Management
VOR icon

Millennium Management’s Vor Biopharma VOR Stock Holding History

Millennium Management’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,500
Closed -$178K – 6503
2025
Q2 		$178K Buy
+5,500
New +$48.6K ﹤0.01% 5398

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management's VOR Position: Q1 2026 in Review

Millennium Management increased its Vor Biopharma (VOR) stake by 15% in Q1 2026, buying an estimated $480K and bringing the position to 258,587 shares worth $4.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

Millennium Management first reported a position in VOR in Q2 2021 and has held it in 15 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Millennium Management held 258,587 shares of Vor Biopharma worth $4.61M as of Q1 2026.
  • Millennium Management bought 34,053 Vor Biopharma shares in Q1 2026, an estimated $480K.
  • Vor Biopharma made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3039 holding.
  • Millennium Management first reported a position in Vor Biopharma in Q2 2021 and has held it in 15 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.